Also trades as: LLY.TO (TSX) · $vol 2M · LLY.DE (XETRA) · $vol 2M · LLY.SW (SIX) · $vol 0M

$1,281.91

+2.77 (+0.22%)

Weekly Expected Move ±4.4%

$1162 $1218 $1273 $1329 $1385

NYSE · Healthcare · Drug Manufacturers - General · Tech Score Strong Buy · Power 82 · $1.21T mcap · 848M float · 0.307% daily turnover · Short 48% of daily vol

Credit Risk of going bust: lower than 84% of companies Debt: 4.4% of company value Bonds: $1.28B held by 465 funds, 44 bp over Treasuries → details ▾

Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $5.05 (down 99.6%), Eli Lilly and Company would be worth roughly what it owes.
Total debt $54.91B against a stock market value of $1.21T.
Distance to default 10.87 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $30.98B (short-term plus half of long-term), stock volatility 34.6%; Altman Z 8.57. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WIDE EDGE

86.5 / 100

NoneWeakNarrowWide

Primary source: Efficient Scale · ROIC: 39.2% · 5Y Avg: 34.4%

Cost Advantage

Intangibles

Switching Cost

Network Effect

Scale ★

100

The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. LLY possesses a Wide competitive edge (86.5/100) — durable structural advantages that are difficult for competitors to erode. The primary source of advantage is Efficient Scale. ROIC of 39.2% confirms the company is generating returns well above its cost of capital — a hallmark of durable competitive advantages.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets

$940

Low

$1354

Avg Target

$1450

High

Based on 13 analysts since Aug 5, 2026 earnings

Analyst Recommendations

Strong Buy: 0Buy: 33Hold: 9Sell: 3Strong Sell: 0

Rating Summary

ConsensusBuy

Avg Target$1354.46

Analysts13

Price Target Change History

Date	Firm	Analyst	Old	New	Change	Upside @ Call	Stock@Call
2026-10-26	Bernstein	Courtney Breen	$1385	$1450	+65	+13.9%	$1273.46
2026-10-21	Leerink Partners	—	$1232	$1316	+84	+4.0%	$1265.92
2026-10-20	Goldman Sachs	—	$1260	$1413	+153	+8.7%	$1300.46
2026-10-08	Cantor Fitzgerald	Carter Gould	$1410	$1440	+30	+21.1%	$1188.72
2026-10-07	Morgan Stanley	—	$1419	$1430	+11	+20.7%	$1184.47
2026-09-18	Guggenheim	Seamus Fernandez	$1273	$1284	+11	+11.4%	$1152.13
2026-09-15	Berenberg Bank	Kerry Holford	$1135	$1400	+265	+23.0%	$1137.75
2026-09-10	HSBC	—	$1251	$940	-311	-16.4%	$1124.16
2026-08-07	UBS	—	$1425	$1376	-49	+16.9%	$1177.33
2026-08-06	Cantor Fitzgerald	—	$1350	$1410	+60	+19.4%	$1181.00
2026-08-06	Morgan Stanley	—	$1347	$1419	+72	+21.3%	$1169.86
2026-08-06	Wells Fargo	Mohit Bansal	$1280	$1330	+50	+13.7%	$1169.86
2026-08-06	BMO Capital	Evan Seigerman	$1300	$1400	+100	+19.7%	$1169.86
2026-07-14	Bernstein	—	$1300	$1385	+85	+16.9%	$1185.08
2026-07-13	UBS	—	$1370	$1425	+55	+19.8%	$1189.91
2026-07-13	Guggenheim	—	$1161	$1273	+112	+7.1%	$1188.58
2026-07-09	UBS	—	$1250	$1370	+120	+12.1%	$1222.12
2026-07-08	Truist Financial	—	$1281	$1370	+89	+11.6%	$1227.07
2026-07-08	RBC Capital	—	$1250	$1500	+250	+22.0%	$1229.22
2026-07-08	Morgan Stanley	Terence Flynn	$1344	$1347	+3	+9.0%	$1235.56
2026-07-06	Cantor Fitzgerald	—	$1230	$1350	+120	+11.5%	$1210.50
2026-06-25	Leerink Partners	David Risinger	$1119	$1232	+113	+10.3%	$1117.26
2026-06-22	Berenberg Bank	Kerry Holford	$830	$1135	+305	+2.1%	$1111.67
2026-06-09	Jefferies	—	$1300	$1350	+50	+18.1%	$1143.35
2026-05-26	HSBC	—	$1070	$1251	+181	+17.5%	$1065.00
2026-05-26	Leerink Partners	David Risinger	$1234	$1119	-115	+5.1%	$1065.00
2026-05-21	Wolfe Research	—	Initiated	$1350	—	+30.1%	$1037.82
2026-05-05	Barclays	Emily Field	$1350	$1400	+50	+44.6%	$967.93
2026-05-01	Morgan Stanley	—	$1327	$1344	+17	+39.8%	$961.55
2026-05-01	Cantor Fitzgerald	Carter Gould	$985	$1230	+245	+26.7%	$970.67
2026-04-10	Morgan Stanley	—	$1313	$1327	+14	+41.3%	$939.31
2026-03-13	Jefferies	Akash Tewari	$1015	$1300	+285	+29.9%	$1000.78
2026-03-06	Deutsche Bank	James Shin	$1025	$1285	+260	+29.8%	$990.31
2026-03-05	Morgan Stanley	Terence Flynn	$1290	$1313	+23	+35.0%	$972.50
2026-02-24	RBC Capital	Trung Huynh	Initiated	$1250	—	+19.9%	$1042.15
2026-02-19	Barclays	—	$913	$1350	+437	+31.9%	$1023.22
2026-02-10	Loop Capital Markets	Ilya Zubkov	$950	$1200	+250	+17.1%	$1025.00
2026-02-05	Scotiabank	—	Initiated	$1300	—	+25.3%	$1037.12
2026-02-05	Truist Financial	—	$1182	$1281	+99	+24.7%	$1027.51
2026-02-05	Goldman Sachs	—	$1145	$1260	+115	+13.8%	$1107.12
2026-02-05	Wells Fargo	Mohit Bansal	$1000	$1280	+280	+15.6%	$1107.12
2026-02-05	BMO Capital	Evan Seigerman	$1200	$1300	+100	+17.4%	$1107.12
2026-01-20	Guggenheim	—	$1163	$1161	-2	+11.8%	$1038.40
2026-01-06	UBS	Michael Yee	$1050	$1250	+200	+17.5%	$1064.04
2026-01-05	Leerink Partners	David Risinger	$715	$1234	+519	+14.2%	$1080.36
2025-12-16	Daiwa	Narumi Nakagiri	$700	$1230	+530	+15.7%	$1062.71
2025-12-15	Goldman Sachs	—	$856	$1145	+289	+10.2%	$1039.04
2025-12-10	HSBC	—	$700	$1070	+370	+9.0%	$981.67
2025-12-04	BMO Capital	—	$1100	$1200	+100	+16.1%	$1033.56
2025-12-03	Guggenheim	—	$948	$1163	+215	+11.2%	$1046.12

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

Oct 27, 2026

DCF

ROE

ROA

D/E

P/E

P/B

The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. LLY receives an overall rating of B. Strongest factors: ROE (5/5), ROA (5/5). Areas of concern: D/E (1/5), P/E (1/5), P/B (1/5).

Rating Change History

Date	From	To
2026-07-25	B+	B
2026-07-01	B	B+
2026-05-18	B+	B
2026-05-06	B	B+
2026-05-01	B+	B
2026-04-30	B	B+
2026-02-17	C-	B
2026-02-05	B+	C-
2026-01-03	B	B+

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 78 Grade A+

Profitability

100

Balance Sheet

Earnings Quality

Growth

Value

Momentum

Safety

100

Cash Flow

The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. LLY scores highest in Safety (100/100) and lowest in Value (37/100). An overall grade of A+ places LLY among the highest-quality companies in its peer group.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score

7.83

Safe Zone

Piotroski F-Score

9/9

✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓

Beneish M-Score

-2.01

Unlikely Manipulator

Ohlson O-Score

-8.38

Bankruptcy prob: 0.0%

Low Risk

Credit Rating

Score: 86.2/100

Trend: Improving

Earnings Quality

100/100

OCF/NI: 1.05x

Accruals: -1.1%

The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. LLY scores 7.83, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. LLY scores 9/9, signaling strong financial health across all three dimensions. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. LLY's score of -2.01 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. LLY's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. LLY receives an estimated rating of AA (score: 86.2/100), with a improving trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). LLY's score of 100/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E

42.89x

PEG

0.45x

P/S

15.15x

P/B

33.77x

P/FCF

53.45x

P/OCF

38.17x

EV/EBITDA

28.27x

EV/Revenue

14.03x

EV/EBIT

29.51x

EV/FCF

55.74x

Earnings Yield

2.49%

FCF Yield

1.87%

Shareholder Yield

1.12%

Graham Number

$159.66

Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 42.9x earnings, LLY is priced for high growth expectations. Graham's intrinsic value formula yields $159.66 per share, 703% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden

0.795

NI / EBT

Interest Burden

0.887

EBT / EBIT

EBIT Margin

0.476

EBIT / Rev

Asset Turnover

0.655

Rev / Assets

Equity Multiplier

4.663

Assets / Equity

ROE

102.4%

The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. LLY's ROE of 102.4% is driven by financial leverage (equity multiplier: 4.66x). Note: high leverage means ROE is amplified by debt rather than operational performance.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate

15.00%

Fair P/E

38.50x

Intrinsic Value

$1150.63

Price/Value

1.04x

Margin of Safety

-4.24%

Premium

4.24%

Assessment

Neutral

Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with LLY's realized 15.0% 3-year EPS CAGR, capped at 15% — demonstrated performance rather than forecasts, held to a rate companies have historically sustained. LLY actually compounded EPS at 63.4% over three years; the model uses 15%, the highest rate it will extrapolate — of 4,457 company-quarters that grew faster than 200%, none sustained it over the following seven years. LLY trades at a 4% premium to its adjusted intrinsic value of $1150.63, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 38.5x compares to the current market P/E of 42.9x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price

$1281.91

Median 1Y

$1725.40

5th Pctile

$954.43

95th Pctile

$3115.16

Ann. Volatility

33.4%

Analyst Target

$1354.46

25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

Executive	Salary	Stock	Total
David A. Ricks Chair, President, and Chief Executive Officer	$1,700,000	$23,325,000	$36,698,337
Daniel M. Skovronsky, M.D., Ph.D. Executive Vice President, Chief Scientific and Product Officer and President, Lilly Research Labs	$1,490,385	$12,000,000	$17,786,576
Anat Hakim President, Vice President, General Counsel and Secretary	$1,000,000	$6,000,000	$9,845,518
Lucas Montarce Financial Vice President and Chief Financial Officer	$1,000,000	$5,000,000	$8,483,315
Jake Van Naarden Executive Vice President and President, Lilly Oncology and Head of Corporate Business Development	$920,192	$4,500,000	$7,586,097

CEO Pay Ratio

165:1

CEO-to-Employee Pay Ratio

CEO Total Comp: $36,698,337

Avg Employee Cost (SGA/emp): $221,880

Employees: 50,000

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees

50,000

+6.4% YoY

Revenue / Employee

$1,303,580

Rev: $65,179,000,000

Profit / Employee

$412,766

NI: $20,638,300,000

SGA / Employee

$221,880

Avg labor cost proxy

R&D / Employee

$266,750

Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
ROE	94.9%	76.4%	75.5%	75.9%	67.7%	63.6%	55.4%	66.3%	46.9%	48.9%	51.1%	59.6%	65.7%	84.8%	77.7%	86.7%	96.8%	1.0%	1.1%	1.0%	1.02%
ROA	13.0%	11.7%	13.1%	12.0%	12.6%	12.7%	11.4%	12.8%	9.5%	9.2%	10.5%	11.6%	12.5%	14.8%	14.5%	16.0%	19.3%	21.6%	24.5%	22.0%	21.96%
ROIC	32.6%	32.5%	34.4%	36.4%	35.4%	32.2%	26.4%	27.4%	27.5%	26.1%	26.3%	29.0%	29.4%	32.9%	32.3%	34.3%	38.8%	38.6%	39.9%	39.2%	39.23%
ROCE	20.7%	19.2%	21.1%	20.9%	21.6%	22.1%	17.9%	21.4%	18.3%	19.2%	17.9%	21.5%	21.3%	26.7%	24.4%	28.7%	31.3%	34.1%	40.6%	40.1%	40.07%
Gross Margin	78.9%	74.4%	73.5%	78.0%	77.3%	78.8%	76.6%	78.3%	80.4%	80.9%	80.9%	80.8%	81.0%	82.2%	82.5%	84.3%	82.9%	85.1%	81.9%	85.8%	85.78%
Operating Margin	31.5%	30.9%	34.1%	26.9%	29.4%	30.2%	24.6%	28.1%	37.3%	34.1%	31.2%	39.1%	39.8%	42.8%	42.5%	45.8%	47.6%	45.5%	49.4%	54.2%	54.22%
Net Margin	16.4%	21.6%	24.4%	14.7%	20.9%	26.5%	19.3%	21.2%	-0.6%	23.4%	25.6%	26.3%	8.5%	32.6%	21.7%	36.4%	31.7%	34.4%	37.4%	30.9%	30.88%
EBITDA Margin	25.3%	29.6%	33.0%	23.4%	29.0%	35.0%	28.7%	31.0%	10.1%	32.4%	35.5%	36.4%	19.7%	42.5%	32.7%	48.2%	44.8%	43.5%	52.0%	56.5%	56.55%
FCF Margin	16.6%	19.0%	19.9%	17.0%	18.3%	16.1%	13.7%	10.9%	-0.5%	-9.2%	-10.6%	-9.1%	-5.3%	1.1%	-2.6%	-0.1%	15.2%	13.8%	18.8%	25.2%	25.17%
OCF Margin	24.9%	25.6%	27.6%	25.8%	27.6%	26.3%	24.2%	20.9%	19.1%	12.4%	10.2%	11.6%	14.8%	19.6%	19.0%	20.5%	27.0%	25.8%	28.3%	35.3%	35.25%
ROE 3Y Avg	snapshot only																				69.50%
ROE 5Y Avg	snapshot only																				66.77%
ROA 3Y Avg	snapshot only																				14.22%
ROIC 3Y Avg	snapshot only																				29.72%
ROIC Economic	snapshot only																				35.92%
Cash ROA	snapshot only																				19.74%
Cash ROIC	snapshot only																				35.18%
CROIC	snapshot only																				25.12%
NOPAT Margin	snapshot only																				39.32%
Pretax Margin	snapshot only																				42.17%
R&D / Revenue	snapshot only																				18.32%
SGA / Revenue	snapshot only																				15.63%
SBC / Revenue	snapshot only																				0.81%

Valuation

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
P/E Ratio	35.54	45.46	42.97	49.92	47.17	54.36	56.16	67.30	100.62	99.16	113.16	110.34	94.93	65.35	66.59	50.64	37.19	46.76	32.60	40.13	42.888
P/S Ratio	7.65	8.96	8.98	9.77	9.73	11.89	11.53	14.82	15.65	15.23	19.33	20.81	19.44	15.36	15.09	13.12	11.52	14.81	11.41	13.46	15.147
P/B Ratio	27.36	28.26	28.22	33.25	28.26	31.87	28.54	39.52	44.73	48.24	54.21	59.73	55.80	48.77	46.91	38.25	28.78	36.37	26.41	31.64	33.767
P/FCF	45.93	47.10	45.22	57.41	53.31	73.79	84.37	136.17	-3043.76	-164.86	-182.82	-229.39	-364.66	1354.90	-582.44	-13921.34	75.91	107.56	60.68	53.45	53.452
P/OCF	30.67	34.95	32.57	37.92	35.22	45.24	47.59	71.00	81.86	122.56	188.98	179.64	131.71	78.49	79.38	63.89	42.63	57.40	40.23	38.17	38.169
EV/EBITDA	26.22	33.17	31.86	36.49	35.14	40.82	41.40	49.62	64.24	63.25	74.13	74.42	65.70	47.43	47.61	37.39	28.36	35.81	25.31	28.27	28.267
EV/Revenue	8.12	9.42	9.46	10.26	10.18	12.38	12.08	15.36	16.20	15.88	19.99	21.47	20.12	16.04	15.81	13.80	12.07	15.35	11.93	14.03	14.032
EV/EBIT	31.62	41.07	39.22	45.46	43.28	49.52	50.45	59.10	79.04	76.98	88.41	86.91	75.81	53.66	53.64	41.37	30.66	37.93	26.57	29.51	29.509
EV/FCF	48.80	49.51	47.61	60.25	55.77	76.84	88.39	141.15	-3150.94	-171.94	-189.04	-236.62	-377.33	1414.06	-610.24	-14645.60	79.52	111.49	63.48	55.74	55.744
Earnings Yield	2.8%	2.2%	2.3%	2.0%	2.1%	1.8%	1.8%	1.5%	1.0%	1.0%	0.9%	0.9%	1.1%	1.5%	1.5%	2.0%	2.7%	2.1%	3.1%	2.5%	2.49%
FCF Yield	2.2%	2.1%	2.2%	1.7%	1.9%	1.4%	1.2%	0.7%	-0.0%	-0.6%	-0.5%	-0.4%	-0.3%	0.1%	-0.2%	-0.0%	1.3%	0.9%	1.6%	1.9%	1.87%
PEG Ratio	snapshot only																				0.453
Price/Tangible Book	snapshot only																				154.903
EV/OCF	snapshot only																				39.806
EV/Gross Profit	snapshot only																				16.703
Acquirers Multiple	snapshot only																				28.375
Shareholder Yield	snapshot only																				1.12%
Graham Number	snapshot only																				$159.66

Leverage & Solvency

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Current Ratio	1.30	1.23	1.27	1.10	1.13	1.05	1.30	1.13	1.05	0.94	1.35	1.11	1.27	1.15	1.37	1.28	1.55	1.58	1.50	1.35	1.355
Quick Ratio	1.02	0.97	0.98	0.85	0.88	0.80	1.02	0.87	0.82	0.73	1.03	0.87	0.97	0.89	1.06	1.00	1.24	1.19	1.10	1.00	1.003
Debt/Equity	2.20	1.88	1.77	1.97	1.58	1.52	1.69	1.70	1.80	2.34	2.05	2.13	2.19	2.37	2.44	2.18	1.79	1.60	1.39	1.62	1.621
Net Debt/Equity	1.71	1.45	1.49	1.65	1.31	1.32	1.36	1.45	1.58	2.07	1.84	1.88	1.94	2.13	2.24	1.99	1.37	1.33	1.22	1.36	1.357
Debt/Assets	0.35	0.35	0.35	0.36	0.33	0.33	0.36	0.34	0.35	0.39	0.41	0.40	0.41	0.43	0.43	0.40	0.37	0.38	0.37	0.39	0.386
Debt/EBITDA	1.99	2.10	1.90	2.06	1.88	1.88	2.34	2.06	2.49	2.94	2.71	2.57	2.49	2.21	2.37	2.03	1.68	1.52	1.27	1.39	1.388
Net Debt/EBITDA	1.54	1.61	1.60	1.72	1.55	1.62	1.88	1.75	2.19	2.60	2.44	2.27	2.21	1.98	2.17	1.85	1.29	1.26	1.12	1.16	1.162
Interest Coverage	20.52	19.12	20.99	19.82	20.91	21.53	18.98	19.74	15.23	14.49	14.44	15.36	15.62	17.24	17.10	19.52	26.09	33.16	36.73	38.67	38.672
Equity Multiplier	6.21	5.44	5.03	5.51	4.71	4.65	4.75	4.95	5.16	5.94	4.99	5.30	5.31	5.55	5.67	5.52	4.83	4.24	3.74	4.20	4.200
Cash Ratio	snapshot only																				0.187
Debt Service Coverage	snapshot only																				40.372
Cash to Debt	snapshot only																				0.163
FCF to Debt	snapshot only																				0.365
Defensive Interval	snapshot only																				429.9 days

Efficiency & Turnover

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Asset Turnover	0.60	0.59	0.63	0.61	0.61	0.58	0.55	0.58	0.61	0.60	0.61	0.61	0.61	0.63	0.64	0.62	0.62	0.68	0.70	0.66	0.655
Inventory Turnover	1.87	1.86	1.99	1.81	1.84	1.62	1.47	1.51	1.57	1.40	1.34	1.33	1.26	1.26	1.16	1.06	1.03	0.99	1.00	0.92	0.916
Receivables Turnover	5.14	4.51	4.92	4.77	4.63	4.21	4.00	4.25	4.31	4.27	4.66	4.20	4.43	4.48	4.92	4.23	4.50	4.53	4.74	4.65	4.652
Payables Turnover	4.66	4.46	4.89	4.29	4.39	3.68	3.59	3.17	3.32	3.13	3.18	2.78	2.93	2.89	3.03	2.64	2.82	2.45	2.81	2.50	2.500
DSO	71	81	74	77	79	87	91	86	85	85	78	87	82	81	74	86	81	81	77	78	78.5 days
DIO	195	196	184	202	198	226	249	242	233	260	273	275	289	290	314	345	355	369	365	398	398.4 days
DPO	78	82	75	85	83	99	102	115	110	117	115	132	124	126	120	138	129	149	130	146	146.0 days
Cash Conversion Cycle	188	195	183	193	194	213	238	213	208	229	236	230	247	245	267	293	307	300	312	331	330.9 days
Fixed Asset Turnover	snapshot only																				2.720
Operating Cycle	snapshot only																				476.9 days
Cash Velocity	snapshot only																				8.901
Capital Intensity	snapshot only																				1.786

Growth (YoY)

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Revenue	19.6%	15.4%	15.1%	8.8%	5.3%	0.8%	-5.6%	1.5%	9.7%	19.6%	29.8%	31.9%	27.4%	32.0%	36.4%	36.8%	45.4%	44.7%	47.4%	49.6%	49.58%
Net Income	7.2%	-9.9%	0.6%	-6.2%	1.0%	11.9%	-7.2%	14.2%	-17.3%	-16.1%	7.9%	13.0%	67.8%	1.0%	80.9%	88.0%	1.2%	94.9%	1.3%	93.5%	93.55%
EPS	7.2%	-9.6%	1.5%	-5.5%	6.9%	12.3%	-7.1%	8.6%	-21.3%	-11.8%	13.4%	18.6%	76.0%	1.0%	81.6%	88.9%	1.2%	96.0%	1.3%	94.9%	94.87%
FCF	-9.8%	20.2%	4.7%	2.3%	15.5%	-14.6%	-35.0%	-35.1%	-1.0%	-1.7%	-2.0%	-2.1%	-12.2%	1.2%	66.6%	98.6%	5.1%	16.6%	11.7%	400.5%	400.48%
EBITDA	6.4%	-9.8%	-0.9%	-6.9%	-1.5%	7.7%	-7.1%	11.8%	-4.5%	-1.1%	19.9%	22.9%	54.7%	77.7%	68.0%	75.1%	1.0%	83.5%	1.1%	1.0%	1.01%
Op. Income	23.2%	10.8%	23.6%	26.0%	14.5%	9.9%	-12.3%	-7.9%	9.9%	24.7%	53.3%	67.4%	52.0%	62.2%	70.9%	64.8%	79.4%	69.7%	68.9%	72.2%	72.17%
OCF Growth	snapshot only																				1.57%
Asset Growth	snapshot only																				40.98%
Equity Growth	snapshot only																				85.41%
Debt Growth	snapshot only																				37.60%
Shares Change	snapshot only																				-0.68%
Dividend Growth	snapshot only																				15.74%

Growth (CAGR)

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Revenue 3Y	8.0%	8.3%	9.4%	9.0%	8.9%	8.5%	6.2%	8.7%	11.4%	11.6%	12.1%	13.4%	13.8%	16.7%	18.7%	22.4%	26.7%	31.7%	37.7%	39.2%	39.23%
Revenue 5Y	5.9%	5.9%	6.3%	5.7%	5.4%	4.5%	4.1%	5.7%	7.8%	8.9%	9.9%	11.6%	12.5%	15.1%	16.2%	18.3%	20.7%	21.6%	23.2%	24.4%	24.41%
EPS 3Y	1.4%	23.2%	0.5%	-8.1%	-6.9%	-8.9%	1.2%	5.2%	-3.4%	-3.6%	2.3%	6.8%	14.0%	26.1%	24.1%	34.5%	45.3%	51.8%	67.6%	63.4%	63.45%
EPS 5Y	23.0%	18.7%	26.6%	23.2%	27.0%	—	41.1%	—	64.3%	13.1%	1.3%	0.0%	2.2%	6.2%	16.4%	21.2%	28.6%	28.8%	34.8%	35.0%	34.99%
Net Income 3Y	1.4%	20.0%	-0.7%	-10.1%	-8.8%	-9.1%	0.9%	5.0%	-3.6%	-5.4%	0.3%	6.5%	11.9%	23.8%	21.9%	34.3%	45.1%	49.0%	64.4%	60.2%	60.19%
Net Income 5Y	19.6%	15.3%	22.9%	18.4%	22.1%	—	38.3%	—	61.8%	10.1%	-0.4%	-1.3%	1.0%	4.9%	15.0%	19.7%	27.0%	27.2%	32.9%	34.5%	34.49%
EBITDA 3Y	20.2%	13.1%	21.2%	9.8%	11.2%	7.9%	1.3%	4.5%	0.0%	-1.3%	3.3%	8.6%	13.3%	23.7%	23.2%	34.0%	44.0%	47.8%	61.5%	63.0%	62.98%
EBITDA 5Y	13.3%	9.7%	13.8%	10.8%	13.4%	16.8%	8.6%	17.0%	10.3%	9.0%	14.7%	12.7%	15.2%	17.2%	15.9%	19.7%	25.6%	25.7%	31.1%	35.1%	35.14%
Gross Profit 3Y	7.3%	7.0%	8.0%	8.1%	7.9%	7.6%	5.6%	8.3%	11.6%	12.4%	14.2%	16.6%	16.7%	20.4%	22.4%	25.8%	30.7%	35.6%	41.0%	42.9%	42.86%
Gross Profit 5Y	6.4%	6.2%	6.5%	6.4%	6.0%	5.5%	5.2%	6.5%	8.4%	9.5%	10.7%	12.5%	13.4%	15.8%	17.0%	19.5%	22.1%	23.4%	25.6%	27.5%	27.52%
Op. Income 3Y	13.6%	8.7%	13.6%	15.1%	14.2%	13.0%	5.9%	9.1%	15.8%	15.0%	18.4%	24.8%	24.1%	30.5%	31.9%	36.4%	44.2%	50.8%	64.1%	68.1%	68.07%
Op. Income 5Y	16.9%	15.3%	16.2%	15.0%	13.7%	14.4%	10.3%	10.5%	13.1%	12.0%	14.6%	18.6%	20.0%	23.9%	25.5%	29.1%	33.4%	33.1%	36.8%	40.7%	40.68%
FCF 3Y	16.4%	29.1%	38.0%	14.2%	26.0%	9.7%	0.8%	-13.2%	—	—	—	—	—	-54.4%	—	—	19.1%	24.9%	53.1%	84.1%	84.15%
FCF 5Y	13.4%	6.9%	5.7%	1.1%	2.6%	1.4%	-2.6%	4.8%	—	—	—	—	—	-31.9%	—	—	12.0%	14.9%	19.5%	32.9%	32.90%
OCF 3Y	5.9%	9.5%	14.4%	15.0%	23.2%	15.8%	11.0%	-1.0%	-2.7%	-13.3%	-22.2%	-14.0%	-4.5%	6.7%	4.8%	13.4%	25.7%	30.9%	45.1%	65.8%	65.82%
OCF 5Y	13.7%	7.9%	7.9%	5.4%	6.2%	6.0%	3.3%	2.0%	1.1%	-5.2%	-7.4%	-1.8%	6.9%	12.8%	13.7%	11.5%	19.3%	20.9%	21.3%	31.7%	31.68%
Assets 3Y	2.6%	3.6%	7.3%	6.8%	7.8%	8.0%	9.0%	9.3%	9.6%	11.1%	10.9%	14.6%	16.2%	17.3%	24.0%	29.0%	34.3%	31.5%	29.9%	37.4%	37.43%
Assets 5Y	5.1%	4.7%	4.5%	2.8%	2.0%	1.9%	3.7%	5.3%	5.4%	7.8%	11.0%	13.2%	14.8%	14.9%	16.8%	19.2%	21.2%	19.3%	20.0%	24.4%	24.37%
Equity 3Y	-16.0%	-3.0%	55.5%	45.4%	43.9%	59.9%	53.8%	39.3%	32.5%	24.1%	22.9%	28.1%	22.4%	16.5%	19.1%	28.8%	33.2%	35.6%	40.7%	45.2%	45.21%
Book Value 3Y	-14.0%	-0.3%	57.3%	48.7%	46.8%	60.3%	54.2%	39.7%	32.8%	26.4%	25.4%	28.4%	24.7%	18.6%	21.3%	29.0%	33.4%	38.1%	43.5%	48.2%	48.16%
Dividend 3Y	7.1%	7.6%	5.9%	7.1%	6.8%	4.9%	5.0%	5.0%	5.0%	6.8%	6.9%	5.0%	6.8%	6.7%	6.7%	4.9%	4.9%	6.8%	6.8%	6.9%	6.88%

Growth Quality

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Revenue Stability	0.74	0.76	0.79	0.78	0.75	0.76	0.76	0.88	0.92	0.90	0.81	0.84	0.88	0.85	0.78	0.82	0.82	0.81	0.79	0.79	0.793
Earnings Stability	0.44	0.47	0.63	0.36	0.41	0.44	0.38	0.28	0.14	0.01	0.00	0.00	0.00	0.06	0.48	0.60	0.54	0.59	0.59	0.69	0.691
Margin Stability	0.97	0.97	0.97	0.97	0.97	0.97	0.97	0.98	0.98	0.98	0.97	0.97	0.97	0.97	0.96	0.97	0.96	0.96	0.96	0.95	0.951
Rev. Growth Consistency	1.00	1.00	1.00	1.00	1.00	1.00	0.00	1.00	1.00	1.00	0.50	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.000
Earn. Growth Consistency	0.50	0.00	1.00	0.00	1.00	0.50	0.00	0.50	0.00	0.00	0.50	1.00	0.50	0.50	1.00	1.00	1.00	1.00	1.00	1.00	1.000
FCF Positive Streak	1	1	1	1	1	1	1	1	0	0	0	0	0	0	0	0	0	1	0	0	0
Earnings Persistence	0.97	0.96	1.00	0.98	1.00	0.95	0.97	0.94	0.93	0.94	0.97	0.95	0.50	0.50	0.50	0.50	0.50	0.50	0.50	0.50	0.500
Earnings Smoothness	0.93	0.90	0.99	0.94	0.99	0.89	0.93	0.87	0.81	0.83	0.92	0.88	0.49	0.32	0.42	0.39	0.25	0.36	0.22	0.36	0.363
ROE Trend	-0.98	-1.52	-0.68	-0.49	-0.36	-0.27	-0.26	-0.22	-0.24	-0.12	-0.10	-0.09	0.07	0.21	0.21	0.19	0.26	0.16	0.22	0.14	0.140
Gross Margin Trend	-0.03	-0.04	-0.03	-0.00	-0.01	0.01	0.03	0.03	0.03	0.04	0.04	0.04	0.04	0.03	0.03	0.03	0.03	0.04	0.03	0.02	0.023
FCF Margin Trend	-0.00	0.02	0.01	-0.03	-0.01	-0.03	-0.07	-0.07	-0.18	-0.27	-0.27	-0.23	-0.14	-0.02	-0.04	-0.01	0.18	0.18	0.25	0.30	0.298
Sustainable Growth Rate	47.5%	34.1%	36.1%	31.7%	29.3%	27.6%	19.7%	27.5%	9.9%	10.9%	16.0%	24.1%	30.2%	47.3%	43.7%	55.1%	69.4%	74.9%	83.9%	80.2%	80.25%
Internal Growth Rate	6.9%	5.5%	6.7%	5.3%	5.8%	5.8%	4.2%	5.6%	2.0%	2.1%	3.4%	4.9%	6.1%	9.0%	8.9%	11.3%	16.1%	19.0%	23.6%	20.8%	20.78%

Cash Flow Quality

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
OCF/Net Income	1.16	1.30	1.32	1.32	1.34	1.20	1.18	0.95	1.23	0.81	0.60	0.61	0.72	0.83	0.84	0.79	0.87	0.81	0.81	1.05	1.051
FCF/OCF	0.67	0.74	0.72	0.66	0.66	0.61	0.56	0.52	-0.03	-0.74	-1.03	-0.78	-0.36	0.06	-0.14	-0.00	0.56	0.53	0.66	0.71	0.714
FCF/Net Income	snapshot only																				0.751
OCF/EBITDA	snapshot only																				0.710
CapEx/Revenue	8.3%	6.6%	7.7%	8.8%	9.4%	10.2%	10.6%	10.0%	19.6%	21.7%	20.8%	20.7%	20.1%	18.4%	21.6%	20.6%	11.9%	12.0%	9.6%	10.1%	10.08%
CapEx/Depreciation	snapshot only																				4.822
Accruals Ratio	-0.02	-0.04	-0.04	-0.04	-0.04	-0.03	-0.02	0.01	-0.02	0.02	0.04	0.04	0.04	0.02	0.02	0.03	0.02	0.04	0.05	-0.01	-0.011
Sloan Accruals	snapshot only																				0.036
Cash Flow Adequacy	snapshot only																				2.033
Earnings Quality Score	snapshot only																				1.000

Dividends & Buybacks

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Dividend Yield	1.4%	1.2%	1.2%	1.2%	1.2%	1.0%	1.1%	0.9%	0.8%	0.8%	0.6%	0.5%	0.6%	0.7%	0.7%	0.7%	0.8%	0.6%	0.7%	0.5%	0.52%
Dividend/Share	$3.12	$3.24	$3.36	$3.67	$3.79	$3.72	$3.86	$4.00	$4.15	$4.50	$4.67	$4.84	$5.01	$5.18	$5.39	$5.59	$5.79	$6.00	$6.23	$6.47	$6.69
Payout Ratio	50.0%	55.3%	52.2%	58.2%	56.8%	56.6%	64.5%	58.5%	78.9%	77.7%	68.8%	59.6%	54.1%	44.2%	43.7%	36.5%	28.3%	26.1%	22.1%	21.7%	21.66%
FCF Payout Ratio	64.6%	57.3%	54.9%	66.9%	64.1%	76.9%	96.9%	1.2%	—	—	—	—	—	9.2%	—	—	57.7%	60.0%	41.1%	28.8%	28.85%
Total Payout Ratio	58.3%	77.7%	97.0%	97.7%	94.1%	80.6%	77.7%	70.1%	93.9%	92.0%	68.8%	59.6%	59.5%	67.8%	77.1%	68.3%	53.6%	46.0%	42.9%	44.8%	44.77%
Div. Increase Streak	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
Chowder Number	0.16	0.16	0.16	0.16	0.16	0.16	0.16	0.16	0.16	0.16	0.16	0.16	0.16	0.16	0.16	0.16	0.16	0.16	0.16	0.15	0.155
Buyback Yield	0.2%	0.5%	1.0%	0.8%	0.8%	0.4%	0.2%	0.2%	0.1%	0.1%	0.0%	0.0%	0.1%	0.4%	0.5%	0.6%	0.7%	0.4%	0.6%	0.6%	0.58%
Net Buyback Yield	0.2%	0.5%	1.0%	0.8%	0.8%	0.4%	0.2%	0.2%	0.1%	0.1%	0.0%	0.0%	0.1%	0.4%	0.5%	0.6%	0.7%	0.4%	0.6%	0.6%	0.58%
Total Shareholder Return	1.6%	1.7%	2.3%	2.0%	2.0%	1.5%	1.4%	1.0%	0.9%	0.9%	0.6%	0.5%	0.6%	1.0%	1.2%	1.3%	1.4%	1.0%	1.3%	1.1%	1.12%

DuPont Factors

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Tax Burden (NI/EBT)	0.88	0.91	0.91	0.91	0.92	0.92	0.91	0.89	0.81	0.80	0.81	0.82	0.82	0.84	0.82	0.82	0.82	0.80	0.81	0.80	0.795
Interest Burden (EBT/EBIT)	0.95	0.95	0.95	0.95	0.95	0.95	0.95	0.95	0.93	0.93	0.93	0.93	0.94	0.94	0.94	0.95	0.96	0.98	0.96	0.89	0.887
EBIT Margin	0.26	0.23	0.24	0.23	0.24	0.25	0.24	0.26	0.20	0.21	0.23	0.25	0.27	0.30	0.29	0.33	0.39	0.40	0.45	0.48	0.476
Asset Turnover	0.60	0.59	0.63	0.61	0.61	0.58	0.55	0.58	0.61	0.60	0.61	0.61	0.61	0.63	0.64	0.62	0.62	0.68	0.70	0.66	0.655
Equity Multiplier	7.32	6.53	5.78	6.33	5.37	5.01	4.88	5.20	4.95	5.30	4.88	5.14	5.24	5.72	5.37	5.43	5.01	4.69	4.39	4.66	4.663

Per Share

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
EPS (Diluted TTM)	$6.24	$5.85	$6.45	$6.30	$6.68	$6.57	$5.99	$6.84	$5.25	$5.80	$6.79	$8.12	$9.25	$11.73	$12.33	$15.34	$20.49	$22.98	$28.21	$29.89	$29.89
Book Value/Share	$8.11	$9.42	$9.82	$9.46	$11.14	$11.21	$11.79	$11.65	$11.82	$11.92	$14.18	$15.00	$15.73	$15.71	$17.50	$20.31	$26.47	$29.55	$34.82	$37.91	$37.96
Tangible Book/Share	$-4.20	$-2.73	$-2.15	$-3.15	$-1.05	$-0.66	$0.03	$0.09	$0.37	$-1.19	$1.23	$1.28	$2.14	$2.50	$4.42	$7.33	$12.74	$15.72	$19.75	$7.74	$7.74
Revenue/Share	$29.02	$29.69	$30.85	$32.20	$32.35	$30.04	$29.17	$31.09	$33.79	$37.75	$39.76	$43.05	$45.15	$49.87	$54.41	$59.19	$66.11	$72.58	$80.64	$89.14	$89.27
FCF/Share	$4.83	$5.65	$6.13	$5.48	$5.91	$4.84	$3.99	$3.38	$-0.17	$-3.49	$-4.20	$-3.91	$-2.41	$0.57	$-1.41	$-0.06	$10.04	$9.99	$15.16	$22.44	$22.47
OCF/Share	$7.23	$7.61	$8.51	$8.30	$8.94	$7.90	$7.07	$6.49	$6.46	$4.69	$4.07	$4.99	$6.67	$9.76	$10.35	$12.16	$17.87	$18.72	$22.86	$31.42	$31.47
Cash/Share	$4.00	$4.10	$2.70	$3.03	$3.03	$2.33	$3.87	$2.98	$2.63	$3.24	$2.86	$3.72	$3.89	$3.79	$3.58	$3.94	$11.03	$8.09	$5.90	$10.01	$10.03
EBITDA/Share	$8.99	$8.43	$9.15	$9.05	$9.37	$9.11	$8.51	$9.62	$8.52	$9.48	$10.72	$12.42	$13.83	$16.86	$18.07	$21.85	$28.14	$31.11	$38.02	$44.25	$44.25
Debt/Share	$17.86	$17.71	$17.37	$18.62	$17.58	$17.09	$19.89	$19.83	$21.25	$27.90	$29.00	$31.95	$34.39	$37.25	$42.77	$44.35	$47.29	$47.33	$48.41	$61.44	$61.44
Net Debt/Share	$13.86	$13.61	$14.66	$15.59	$14.55	$14.76	$16.03	$16.85	$18.62	$24.67	$26.14	$28.23	$30.50	$33.46	$39.19	$40.41	$36.26	$39.24	$42.51	$51.42	$51.42

Academic Models

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Altman Z-Score	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	7.828
Altman Z-Prime	snapshot only																				13.683
Piotroski F-Score	7	6	7	6	7	8	6	6	4	5	6	5	7	7	7	8	8	8	7	9	9
Beneish M-Score	-2.35	-2.45	-2.52	-2.61	-2.52	-2.59	-2.45	-2.24	-2.29	-2.08	-2.15	-1.87	-2.14	-2.11	-1.98	-2.05	-1.86	-1.89	-1.74	-2.01	-2.014
Ohlson O-Score	snapshot only																				-8.377
ROIC (Greenblatt)	snapshot only																				81.97%
Net-Net WC	snapshot only																				$-48.93
EVA	snapshot only																				$23338727124.76

Credit

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Credit Rating	snapshot only																				AA
Credit Score	79.50	79.31	82.45	74.90	86.42	79.89	79.90	73.12	71.56	66.40	70.45	69.08	71.25	71.13	71.36	69.85	82.32	82.05	85.27	86.19	86.192
Credit Grade	snapshot only																				3
Credit Trend	snapshot only																				16.338
Implied Spread (bps)	snapshot only																				80.000
Industry Credit Rank	snapshot only																				74
Sector Credit Rank	snapshot only																				82

LLY NYSE

Edge Score

Analyst Insights

Financial Rating

InsiderStreet Scorecard

Risk & Quality Signals

Valuation

DuPont Decomposition (5-Factor)

Graham-Dodd Adjusted Valuation

Profitability Trends

Leverage & Solvency Trends

Efficiency & Working Capital Trends

Growth Trends (YoY %)

Earnings Stability

Monte Carlo Price Simulation

Executive Compensation

C-Suite Compensation

CEO Pay Ratio

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Scaling Efficiency

Sign in to InsiderStreet